Souhaitez-vous accéder aux communiqués récents ?

Austin, TX, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Botulinum Toxin in Urology Market Size, Trends and Insights By Product Type...

Austin, TX, USA, July 01, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Human Fibrinogen Concentrate Market Size, Trends and Insights By Form...

Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and...

GRF manipulates reported debt & EBITDA to artificially reduce reported leverage to 6x which we believe is closer to 10x-13x

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Grifols, S.A....

NEW YORK, Jan. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Grifols, S.A....

NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Grifols, S.A....

NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Grifols,...

We are investigating whether Grifols, S.A. has violated federal securities laws based on allegations in a report by Gotham City Research.

BOSTON, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Grifols S.A. ADR (NASDAQ: GRFS) for potential securities law violations. Investors who have lost money in their Grifols...